Chicago’s Department of Planning Development and the Chicago Plan Commission will soon be operating under a new guideline that will monitor the participation and hiring of “Minority and Women-Owned Business Enterprises” (W/MBEs) with respect to certain complex or large proposed construction projects in the city.
Federal judge tosses some accusations vs testosterone drug makers on eve of Androgel bellwether trials
A Chicago federal judge has dismissed several. but not all of the claims against the maker of a testosterone boosting drug, advanced by several plaintiffs chosen as bellwethers in a class-action lawsuit brought by more than 2,000 plaintiffs from around the U.S. against multiple drug manufacturers, including Besins, AbbVie, Eli Lilly and GlaxoSmithKline.
Other states potentially following standard set by IL biometric privacy law, despite numerous class actions
An Illinois biometrics privacy law is paving the way for emerging legislation in several other states across the country, as more vendors deploy biometric technology in a variety of everyday applications, and as the courts continue to work out the potentially expensive implications of the law's mandates on business.
A class action suit against CVS Pharmacy and its MinuteClinic will proceed after a federal judge in Chicago denied a motion to dismiss the complaint, saying the drug store chain can’t shake the lawsuit accusing them of breaking federal anti-robocalling laws when the clinic placed calls to people’s mobile phones to remind them about getting flu shots.
A federal judge has tossed, with leave to amend, the bulk of a federal racketeering and fraud class action brought by an Ohio-based health insurer against Abbvie and other makers of testosterone drugs, saying the insurer has not yet backed up with enough particularity its allegations the drugmakers invented the condition known as “low T,” and, through false marketing to doctors, patients and insurers alike, induced insurers and others to pay far more for the drugs to treat the condition.
Judge declines to drop Androgel maker Besins from huge lawsuit over testosterone treatment side effects
A federal judge has declined to drop the Belgian company which makes Androgel and its American licensee from a multi-state class action lawsuit, which alleges the companies’ testosterone restorative drug is not only useless, but harmful. However, the judge did leave the door open that jurisdiction over the case could lay elsewhere.
The online sale of five hotel properties worth a combined $86 million is proceeding after a federal judge in Chicago approved the transaction, which is connected to an ongoing lawsuit regarding a multi-million dollar fraudulent loan scheme. Pennant Management is embroiled in legal proceedings after accusing First Farmers Financial of selling it the federally guaranteed portions of 26 fraudulent loans allegedly worth $180 million.